Vildaprime M 500mg/50mg Tablet
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Metformin (500mg) + Vildagliptin (50mg)
Overview Vildaprime M 500mg/50mg Tablet
Combivir-M 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events such as stroke or myocardial infarction. Combivir-M 500mg/50mg may be administered as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved through adherence to a balanced diet and consistent physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Maintaining blood sugar control and preventing future complications requires consistent medication use alongside the prescribed lifestyle regimen. Dietary and exercise recommendations must be followed diligently. Lifestyle factors significantly influence diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its symptoms and management. This medication is not universally suitable. Prior to commencing treatment, disclose any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption to your physician. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Potential drug interactions necessitate a comprehensive review of all current medications with your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout the treatment period.
Primary Ingredients of Vildaprime M 500mg/50mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Vildaprime M 500mg/50mg Tablet
Managing type 2 diabetes
Major Benefits of Vildaprime M 500mg/50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vildaprime M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Vildaprime M 500mg/50mg Tablet:
- Hypoglycemia (low blood glucose level)
- Trembling
- Headache
- Dizziness
- Nausea
- Weakness
- Gastro-esophageal reflux disease
- Increased sweating
- Decreased appetite
How to use Vildaprime M 500mg/50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildaprime M 500mg/50mg Tablet with a meal.
How Vildaprime M 500mg/50mg Tablet works:
Vildaprime M 500mg/50mg tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vildaprime M 500mg/50mg Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Vildaprime M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Vildaprime M 500mg/50mg tablets are likely incompatible. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Vildaprime M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Vildaprime M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Vildaprime M 500mg/50mg Tablet :
Should you forget a dose of Vildaprime M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vildaprime M 500mg/50mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





